MedTrace Logo

A Rapid Test for Acute Respiratory Illness

NCT03192072 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 783

Last updated 2020-05-27

No results posted yet for this study

Summary

The primary purpose of this study is to support the development of a host response test for acute respiratory illness to identify bacterial, viral or NB/NV etiologies as compared to a clinical adjudication reference standard.

Secondary objectives include:

1. Evaluate the effect of age on the performance of the HR-ARI test
2. Evaluate the effect of race/ethnicity on the performance of the HR-ARI test
3. Evaluate the effect of geography on the performance of the HR-ARI test

Conditions

Interventions

DIAGNOSTIC_TEST

Host Gene Expression

comparison to retrospective clinical adjudication

Sponsors & Collaborators

  • Antibacterial Resistance Leadership Group

    collaborator OTHER

  • Duke University

    lead OTHER

Principal Investigators

  • Christopher Woods, MD, MPH · Duke University

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-17
Primary Completion
2019-09-06
Completion
2019-12-19
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03192072 on ClinicalTrials.gov